Skip to main navigation Skip to search Skip to main content

Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression

  • Ivetta Danylesko
  • , Noga Shem-Tov
  • , Ronit Yerushalmi
  • , Elad Jacoby
  • , Amos Toren
  • , Roni Shouval
  • , Orit Itzhaki
  • , Abraham Avigdor
  • , Avichai Shimoni
  • , Arnon Nagler
  • Sheba Medical Center at Tel Hashomer
  • Tel Aviv University
  • Cornell University
  • Memorial Sloan-Kettering Cancer Center

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science